All Programs

Use the tool below to view all available Eye Health Academy Series

Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Eye on Ocular Health
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Akshay Thomas, M.D., M.S., FASRS
- Akshay Thomas, M.D., M.S., FASRS
The Fundingsland Group: Glaucoma Education
Evolving Strategies in Early- Stage Glaucoma Management
glaucomatoday.com
Retinal Vein Occlusion as a Marker of Systemic Risk
Retinal Vein Occlusion as a Marker of Systemic Risk
Eye on Ocular Health
Retinal Vein Occlusion as a Marker of Systemic Risk
Ashkan Abbey, MD
- Ashkan Abbey, MD
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Eye on Ocular Health
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Jessica Randolph, MD
- Jessica Randolph, MD
NEW EPISODE
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
MinuteCE®
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
NEW EPISODE
Key Takeaways and Practice Integration
Key Takeaways and Practice Integration
MinuteCE®
Key Takeaways and Practice Integration
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
NEW EPISODE
Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
MinuteCE®
Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
Sustained-Release Drug Delivery for Early-Stage Glaucoma
Sustained-Release Drug Delivery for Early-Stage Glaucoma
The Fundingsland Group: Glaucoma Education
Sustained-Release Drug Delivery for Early-Stage Glaucoma
Lorraine M. Provencher, MD; Zarmeena Vendal
- Lorraine M. Provencher, MD
- Zarmeena Vendal
- Inder Paul Singh
- Manjool Shah, MD
- Emily Schehlein, MD
- Swarup Swaminathan, MD
SLT as First-Line Therapy
SLT as First-Line Therapy
The Fundingsland Group: Glaucoma Education
SLT as First-Line Therapy
Emily Schehlein, MD; Zarmeena Vendal, MD
- Emily Schehlein, MD
- Zarmeena Vendal, MD
- Lorraine M. Provencher, MD
- Inder Paul Singh
- Manjool Shah, MD
- Swarup Swaminathan, MD
Personalized Patient-Centered Glaucoma Management
Personalized Patient-Centered Glaucoma Management
The Fundingsland Group: Glaucoma Education
Personalized Patient-Centered Glaucoma Management
Inder Paul Singh; Lorraine M. Provencher, MD
- Inder Paul Singh
- Lorraine M. Provencher, MD
- Zarmeena Vendal, MD
- Manjool Shah, MD
- Emily Schehlein, MD
- Swarup Swaminathan, MD
Contact Lens Success in Modern Optometric Clinics
Contact Lens Success in Modern Optometric Clinics
Modern Optometry
Contact Lens Success in Modern Optometric Clinics
Jacob Lang
- Jacob Lang
New Contact Lens Technology for Patients With Presbyopia, Dry Eye Disease, and Ocular Surface Disease
New Contact Lens Technology for Patients With Presbyopia, Dry Eye Disease, and Ocular Surface Disease
Modern Optometry
New Contact Lens Technology for Patients With Presbyopia, Dry Eye Disease, and Ocular Surface Disease
Melissa Barnett
- Melissa Barnett
Retina Rumble: Debating Modern Treatment Options
Retina Rumble: Debating Modern Treatment Options
CME/CE
Retina Rumble: Debating Modern Treatment Options
Roger A. Goldberg, MD, MBA; Christina Y. Weng, MD, MBA, FASRS
0.50 credits
- Roger A. Goldberg, MD, MBA
- Christina Y. Weng, MD, MBA, FASRS
- Yasha S. Modi, MD
0.50 credits
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Eye on Ocular Health
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
MinuteCE®
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
Katherine E. Talcott, MD; Christina Y. Weng, MD, MBA, FASRS
0.75 credits 5 episodes
- Katherine E. Talcott, MD
- Christina Y. Weng, MD, MBA, FASRS
- Roger A. Goldberg, MD, MBA
0.75 credits 5 episodes
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Eye on Ocular Health
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Ashkan Abbey, MD
- Ashkan Abbey, MD

All Programs

Popular

Title